Tonix Pharmaceuticals Holding Corp. Annual report pursuant to Section 13 and 15(d)

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2016

The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of December 31, 2016 (in thousands):

Description	December 31, 2016		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Cash equivalents	$	10,006	$	10,006	$	—
Marketable securities – available for sale		7,180		5,926		1,254

Total assets	$	17,186	$	15,932	$	1,254

The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of December 31, 2015 (in thousands):

Description	December 31, 2015		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Cash equivalents	$	7,649	$	7,649	$	—
Marketable securities – available for sale		23,841		13,920		9,921

Total assets	$	31,490	$	21,569	$	9,921